A prodrug form of valproic acid
Related Products
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Valpromide

Item No. 46269

Technical Information
Formal Name
2-propyl-pentanamide
CAS Number
2430-27-5
Synonyms
  • VPD
Molecular Formula
C8H17NO
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥10 mg/mlEthanol: Soluble: ≥10 mg/ml
SMILES
CCCC(CCC)C(N)=O
InChi Code
InChI=1S/C8H17NO/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H2,9,10)
InChi Key
OMOMUFTZPTXCHP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Valpromide is a prodrug form of valproic acid (Item Nos. 35739 | 13033).1,2 It is metabolized to valproic acid via hydrolysis in the liver. Formulations containing valpromide have been used in the treatment of epilepsy and bipolar disorder.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bialer, M., and Rubinstein, A. Pharmacokinetics of valpromide in dogs after various modes of administration. Biopharm. Drug Dispos. 5(2), 177-183 (1984).

    2. Billig, H., Ziv, E., Bar-On, H., et alThe disposition of valpromide in rats and the isolated perfused rat liver. Drug Metab. Dispos. 18(2), 238-244 (1990).